Coronavirus research done too fast is testing publishing safeguards, bad science is getting through

A pharmacotherapy specialist who has consulted on infectious disease treatments for decades writing in The Conversation:

‘… I am both exhilarated and worried as I watch the unprecedented pace and implementation of medical research currently being done. Speed is, of course, important when a crisis such as COVID-19 is at hand. But speed – in research, the interpretation and the implementation of science – is a risky endeavor….’

Uncategorized